Bayer announced positive topline results from the global phase III QUASAR study evaluating ... Detailed results will be submitted to regulatory authorities worldwide and presented at upcoming medical ...

That evidence drew on a wide range of medical and scientific disciplines. Justice Keogh found for Bayer, noting pelvic pain and abnormal uterine bleeding are common in pre-menopausal women, and there ...

The Essure device was implanted into women’s fallopian tubes to prevent pregnancy. It left some women with chronic pelvic ...

The official spokesperson for the Ministry of Health and Population, Hossam Abdel-Ghaffar, said the “Your Heart is Your Responsibility” campaign, which aims to raise awareness about cardiovascular ...

Anaveon, a clinical stage, immuno-oncology company, today announced the appointment of Richard Sachse, M.D., Ph.D., as Chief Medical Officer effective February 1, 2025. Dr. Sachse brings more than 25 ...

Swiss immune-oncology specialist Anaveon has appointed Richard Sachse as its chief medical officer (CMO) effective February 1 ...

GE HealthCare Technologies, Inc. GEHC is well-poised for growth in the coming quarters, courtesy of its continued focus on ...

The global medical disposables market is witnessing strong momentum, with revenues projected to grow from an estimated USD ...

An investigation conducted by Canada’s National Observer finds that Bayer colluded with Canadian regulators to obstruct a ...

He emphasized that the situation is being closely monitored across all schools in the county. Local physician Dr. Steven ...

Bayer said its eye treatment aflibercept showed positive results in a late-stage trial, including improved vision gains for people suffering from some retinal diseases.

A groundbreaking antipsychotic, a powerful new antibiotic, and a vaccine-like prophylactic for HIV are some of the most ...